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Introduction
• The 2018 AHA/ACC Blood Cholesterol Guideline 
classifies ASCVD patients as very high-risk 
(VHR) vs not-VHR (NVHR) for future ASCVD 
events
• For VHR patients, the guideline recommends 
treatment with high-intensity or maximally-
tolerated statin therapy, and initiation of non-
statin therapy if the LDL-C persists 70 mg/dL
• VHR classification has important implications 
for ezetimibe and PCSK9 inhibitor eligibility
• There is limited data on the impact of these 
guideline recommendations on large health 
care systems
• We aimed to define the clinical characteristics 
of these two groups within a large multi-state 
healthcare system in the Western United States
Methods
• Retrospective cohort analysis of ASCVD 
patients (defined by EHR ICD-10 codes) from 
the Providence St. Joseph Health system in 
2018 
• VHR was defined by ≥2 major ASCVD events 
(ACS ≤12 months, history of MI >12 months, 
ischemic stroke, or symptomatic PAD) or 1 
major ASCVD event and ≥2 high-risk conditions 
(age ≥65 years, DM, HTN, smoking, 
heterozygous FH, CKD, CHF, persistently 
elevated LDL-cholesterol, or prior CABG/PCI) 
• Patients not meeting these criteria were 
classified as NVHR
Conclusions
• Criteria used to predict the risk of future 
adverse CV events largely divide ASCVD 
patients into groups of similar prevalence
• Nearly all patients with recent ACS and a 
history of MI were VHR
• Similar findings were previously demonstrated 
in an analysis of 27,775 ASCVD patients, with 
55.3% meeting criteria for VHR (JACC 2019) 
• With growing emphasis on individualized risk 
assessment and the need for intensive LDL-C 
reduction, opportunity exists to further refine 
the risk profile of these two at-risk groups
Results
• 57% of adults with ASCVD were classified as 
VHR
• 96% of adults with a history of ACS were 
classified as VHR 
• 99% of adults with a history of MI were 
classified as VHR
• Age ≥65 years, hypertension and diabetes 
were the most prevalent high-risk conditions
References
Colantonio, L; Shannon, E; Orroth, K; Zaha, R; Jackson, E; Rosenson, R; 
Exter, J; Mues, K; Muntner, P. J Am Coll Cardiol. 2019 Nov, 74 (20) 2496-
2507.
Dr Martin reports research support from the Aetna Foundation, the 
American Heart Association, Apple, the David and June Trone Family 
Foundation, Google, iHealth, the Maryland Innovation Initiative, the 
National Institutes of Health, Nokia, and the PJ Schafer Memorial Fund. 
Dr Martin reports personal fees for serving on scientific advisory boards 
for Akcea Therapeutics, Amgen, Esperion, Novo Nordisk, Quest 















Age, years 72 ± 13 70 ± 13 73 ± 12
Sex, male 99365 (55) 41596 (54) 57769 (55)
Race, white 152925 (92) 65829 (93) 87096 (91)
Major ASCVD events
Recent ACS* 51111 (28%) 1968 (3%) 49143 (47%) 96%
History of MI† 40444 (22%) 258 (0.3%) 40186 (39%) 99%
History of ischemic 
stroke 
49305 (27%) 6188 (8%) 43117 (41%) 87%
Symptomatic PAD 30010 (17%) 2303 (3%) 27707 (27%) 92%
High-risk conditions
Age ≥ 65 years 134391 (74%) 52440 (69%) 81951 (79%) 61%
HeFH 3840 (2.1%) 1363 (1.8%) 2477 (2.4%) 65%
History of prior CABG 
surgery or PCI
23181 (13%) 8501 (11%) 14680 (14%) 63%
Diabetes Mellitus 61293 (34%) 20546 (27%) 40747 (39%) 66%
Hypertension 145677 (81%) 53472 (70%) 92205 (89%) 63%
Chronic kidney disease 3572 (2.0%) 1251 (1.6%) 2321 (2.2%) 65%
Current smoking 59016 (33%) 20450 (27%) 38566 (37%) 65%
Persistently elevated 
LDL-C
1566 (0.9%) 566 (0.7%) 1000 (1.0%) 64%
History of CHF 42694 (24%) 12495 (16%) 30199 (29%) 71%
Data presented as n (%) or %
*Within 12 months 
† >12 months prior to major ASCVD event
ASCVD = atherosclerotic cardiovascular disease, ACS = acute coronary syndrome, CABG = coronary artery 
bypass graft, CHF = congestive heart failure, CKD = chronic kidney disease, CV = cardiovascular, DM = diabetes 
mellitus, FH = familial hypercholesterolemia, HTN = hypertension, LDL-C = low-density lipoprotein cholesterol, 
MI = myocardial infarction, PAD = peripheral arterial disease, PCI = percutaneous coronary intervention
